Nathan Kobrinsky, MD
Pediatric Hematology-Oncology · Fargo, NDNPI 1659398329
Payments from drug & device makers
Across 24 payments — averaging $533.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BTG International Inc.$6K
- Octapharma USA, Inc.$4K
- Kedrion Biopharma Inc.$3K
- Bayer$205
- Eisai Inc.$122
- AstraZeneca$88
- plus $103 from 4 others
What the payments were for
- Speaking & faculty fees$8,25064%
- Travel & lodging$3,44827%
- Food & beverage$1,0979%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BTG International Inc. | 5 | $5,706 |
| Octapharma USA, Inc. | 9 | $3,983 |
| Kedrion Biopharma Inc. | 1 | $2,600 |
| Bayer | 2 | $205 |
| Eisai Inc. | 1 | $122 |
| AstraZeneca | 2 | $88 |
| Sobi, Inc | 1 | $53 |
| Shire North American Group Inc | 1 | $19 |
| Bioverativ Therapeutics Inc. | 1 | $18 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in North Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 172 | $106,041 |
| XareltoRivaroxaban | 51 | $36,024 |
| Levothyroxine Sodium | 34 | $2,638 |
| Amlodipine-Valsartan-HctzAmlodipine/Valsartan/Hcthiazid | 13 | $1,721 |
| Ondansetron HclOndansetron Hcl/Pf | 21 | $1,099 |
| Hydroxyurea | 22 | $888 |
| Rosuvastatin Calcium | 71 | $873 |
| Celecoxib | 26 | $867 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $789 |
| Klor-Con M20Potassium Chloride | 14 | $740 |
| Oxycodone Hcl | 21 | $657 |
| ValacyclovirValacyclovir Hcl | 13 | $486 |
| Fluconazole | 12 | $466 |
| Prednisone | 33 | $406 |
| Ondansetron OdtOndansetron | 17 | $400 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Fargo
- Samuel MilanovichFargo$580K
- Samuel AnimFargo$39K
- Jordan DossFargo$233
- Jessica Benjamin-EzeFargo$136
- Lauren HernandezFargo$115
- Melanie ChihakFargo$69
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.